杭州九源基因生物制药股份有限公司:批准最高1亿元人民币H股回购计划至授权期满

美股速递
Aug 19

杭州九源基因生物制药股份有限公司正式通过一项H股回购方案,规模上限设定为1亿元人民币,该计划将持续有效至相关授权期限届满之日。此举标志着公司在资本运作层面迈出重要一步,旨在优化股本结构并提升股东价值。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10